Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
445.2 USD | +1.04% | +5.31% | +9.42% |
15.05. | Vertex Pharmaceuticals Incorporated ernennt Jennifer Schneider zur unabhängigen Direktorin | CI |
14.05. | VERTEX PHARMACEUTICALS INCORPORATED : Bewertung von Wolfe Research zum Kaufen erhalten | ZM |
ETFs investiert in Vertex Pharmaceuticals Incorporated
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
7,67% | 0 M€ | 0.00% | - | |
7,08% | 0 M€ | 0.00% | - | |
5,20% | 2 M€ | -.--% | ||
4,81% | 7 M€ | -.--% | - | |
4,05% | 110 M€ | +10.31% | - | |
3,53% | 1 M€ | +0.15% | - | |
2,32% | 2 M€ | +10.27% | ||
2,28% | 8 M€ | +5.66% | ||
1,99% | 12 M€ | +15.09% | - | |
1,93% | 0 M€ | 0.00% | - | |
1,71% | 2 M€ | -25.75% | ||
1,63% | 17 M€ | +7.73% | - | |
1,61% | 253 M€ | +7.93% | ||
1,58% | 9 M€ | -4.31% | - | |
1,10% | 204 M€ | +10.54% | ||
1,06% | 1 100 M€ | +4.32% | ||
0,87% | 9 M€ | -.--% | - | |
0,82% | 13 M€ | -.--% | - | |
0,82% | 3 M€ | +15.16% | - | |
0,82% | 4 M€ | -.--% | - | |
0,81% | 26 M€ | +16.85% | - | |
0,73% | 15 M€ | 0.00% | - | |
0,69% | 5 M€ | -72.95% | - | |
0,68% | 3 M€ | 0.00% | - | |
0,51% | 727 M€ | +9.36% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+9.42% | 115 Mrd. | |
+11.84% | 106 Mrd. | |
-1.05% | 21.96 Mrd. | |
-14.15% | 21.87 Mrd. | |
-5.29% | 19.21 Mrd. | |
-4.16% | 18.08 Mrd. | |
-38.29% | 17.71 Mrd. | |
+7.99% | 14.32 Mrd. | |
+36.24% | 12.42 Mrd. | |
-24.95% | 8.23 Mrd. |
- Börse
- Aktien
- 882807 Aktie
- ETFs Vertex Pharmaceuticals Incorporated